North America Onychomycosis Treatment Market 2021-2031

North America onychomycosis treatment market is projected to grow by 7.2% annually in the forecast period and reach $2,111.2 million by 2031.

North America onychomycosis treatment market is projected to grow by 7.2% annually in the forecast period and reach $2,111.2 million by 2031, driven by the increasing prevalence of chronic medical ailments, the growing geriatric population, improved therapies and preventative solutions, and the rising healthcare expenditure. Highlighted with 21 tables and 36 figures, this 87-page report “North America Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America onychomycosis treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America onychomycosis treatment market in every aspect of the classification from perspectives of Onychomycosis Type, Treatment Type, Distribution Channel, and Country. Based on Onychomycosis Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Distal Subungual Onychomycosis • White Superficial Onychomycosis • Proximal Subungual Onychomycosis • Candidal Onychomycosis • Other Onychomycosis Types

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Arun Kalwani

Arun Kalwani

Research Analyst

Based on Treatment Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Drug Treatment • Laser Therapy • Photodynamic Therapy • Other Therapies By Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals and Clinics • Online Stores • Retail Pharmacies • Other Distribution Channels Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Onychomycosis Type, Treatment Type and Distribution Channel over the forecast years are also included.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Arun Kalwani

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Bausch Health Companies Inc. Bayer AG Cipla Ltd Dr. Reddys Laboratories Ltd Galderma SA GlaxoSmithKline PLC Johnson & Johnson Lumenis Ltd Medimetriks Pharmaceuticals Inc. Moberg Pharma AB Novartis AG Pfizer Inc. Sanofi SA (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents

  • 1 Introduction 6
  • 1.1 Industry Definition and Research Scope 6
  • 1.1.1 Industry Definition 6
  • 1.1.2 Research Scope 7
  • 1.2 Research Methodology 10
  • 1.2.1 Overview of Market Research Methodology 10
  • 1.2.2 Market Assumption 11
  • 1.2.3 Secondary Data 11
  • 1.2.4 Primary Data 11
  • 1.2.5 Data Filtration and Model Design 12
  • 1.2.6 Market Size/Share Estimation 13
  • 1.2.7 Research Limitations 14
  • 1.3 Executive Summary 15
  • 2 Market Overview and Dynamics 17
  • 2.1 Market Size and Forecast 17
  • 2.1.1 Impact of COVID-19 on World Economy 18
  • 2.1.2 Impact of COVID-19 on the Market 20
  • 2.2 Major Growth Drivers 22
  • 2.3 Market Restraints and Challenges 29
  • 2.4 Emerging Opportunities and Market Trends 32
  • 2.5 Porter’s Fiver Forces Analysis 36
  • 3 Segmentation of North America Market by Onychomycosis Type 40
  • 3.1 Market Overview by Onychomycosis Type 40
  • 3.2 Distal Subungual Onychomycosis 42
  • 3.3 White Superficial Onychomycosis 43
  • 3.4 Proximal Subungual Onychomycosis 44
  • 3.5 Candidal Onychomycosis 45
  • 3.6 Other Onychomycosis Types 46
  • 4 Segmentation of North America Market by Treatment Type 47
  • 4.1 Market Overview by Treatment Type 47
  • 4.2 Drug Treatment 49
  • 4.3 Laser Therapy 50
  • 4.4 Photodynamic Therapy 51
  • 4.5 Other Therapies 52
  • 5 Segmentation of North America Market by Distribution Channel 53
  • 5.1 Market Overview by Distribution Channel 53
  • 5.2 Hospitals and Clinics 55
  • 5.3 Online Stores 56
  • 5.4 Retail Pharmacies 57
  • 5.5 Other Distribution Channels 58
  • 6 North America Market 2021-2031 by Country 59
  • 6.1 Overview of North America Market 59
  • 6.2 U.S. 62
  • 6.3 Canada 65
  • 6.4 Mexico 67
  • 7 Competitive Landscape 69
  • 7.1 Overview of Key Vendors 69
  • 7.2 New Product Launch, Partnership, Investment, and M&A 72
  • 7.3 Company Profiles 73
  • Bausch Health Companies Inc. 73
  • Bayer AG 75
  • Cipla Ltd 76
  • Dr. Reddys Laboratories Ltd 77
  • Galderma SA 78
  • GlaxoSmithKline PLC 79
  • Johnson & Johnson 80
  • Lumenis Ltd 81
  • Medimetriks Pharmaceuticals Inc. 82
  • Moberg Pharma AB 83
  • Novartis AG 84
  • Pfizer Inc. 85
  • Sanofi SA 86
  • RELATED REPORTS 87

List of Figures:

Figure 1. Research Method Flow Chart 10
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 13
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 15
Figure 4. North America Onychomycosis Treatment Market, 2021-2031, $ mn 17
Figure 5. Impact of COVID-19 on Business 20
Figure 6. Primary Drivers and Impact Factors of North America Onychomycosis Treatment Market 22
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 26
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 27
Figure 9. Primary Restraints and Impact Factors of North America Onychomycosis Treatment Market 29
Figure 10. Investment Opportunity Analysis 33
Figure 11. Porter’s Fiver Forces Analysis of North America Onychomycosis Treatment Market 36
Figure 12. Breakdown of North America Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, % of Revenue 41
Figure 13. North America Addressable Market Cap in 2022-2031 by Onychomycosis Type, Value ($ mn) and Share (%) 41
Figure 14. North America Onychomycosis Treatment Market by Onychomycosis Type: Distal Subungual Onychomycosis, 2021-2031, $ mn 42
Figure 15. North America Onychomycosis Treatment Market by Onychomycosis Type: White Superficial Onychomycosis, 2021-2031, $ mn 43
Figure 16. North America Onychomycosis Treatment Market by Onychomycosis Type: Proximal Subungual Onychomycosis, 2021-2031, $ mn 44
Figure 17. North America Onychomycosis Treatment Market by Onychomycosis Type: Candidal Onychomycosis, 2021-2031, $ mn 45
Figure 18. North America Onychomycosis Treatment Market by Onychomycosis Type: Other Onychomycosis Types, 2021-2031, $ mn 46
Figure 19. Breakdown of North America Onychomycosis Treatment Market by Treatment Type, 2021-2031, % of Sales Revenue 48
Figure 20. North America Addressable Market Cap in 2022-2031 by Treatment Type, Value ($ mn) and Share (%) 48
Figure 21. North America Onychomycosis Treatment Market by Treatment Type: Drug Treatment, 2021-2031, $ mn 49
Figure 22. North America Onychomycosis Treatment Market by Treatment Type: Laser Therapy, 2021-2031, $ mn 50
Figure 23. North America Onychomycosis Treatment Market by Treatment Type: Photodynamic Therapy, 2021-2031, $ mn 51
Figure 24. North America Onychomycosis Treatment Market by Treatment Type: Other Therapies, 2021-2031, $ mn 52
Figure 25. Breakdown of North America Onychomycosis Treatment Market by Distribution Channel, 2021-2031, % of Sales Revenue 54
Figure 26. North America Addressable Market Cap in 2022-2031 by Distribution Channel, Value ($ mn) and Share (%) 54
Figure 27. North America Onychomycosis Treatment Market by Distribution Channel: Hospitals and Clinics, 2021-2031, $ mn 55
Figure 28. North America Onychomycosis Treatment Market by Distribution Channel: Online Stores, 2021-2031, $ mn 56
Figure 29. North America Onychomycosis Treatment Market by Distribution Channel: Retail Pharmacies, 2021-2031, $ mn 57
Figure 30. North America Onychomycosis Treatment Market by Distribution Channel: Other Distribution Channels, 2021-2031, $ mn 58
Figure 31. Breakdown of North America Onychomycosis Treatment Market by Country, 2021 and 2031, % of Revenue 60
Figure 32. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 61
Figure 33. U.S. Onychomycosis Treatment Market, 2021-2031, $ mn 63
Figure 34. Canada Onychomycosis Treatment Market, 2021-2031, $ mn 65
Figure 35. Onychomycosis Treatment Market in Mexico, 2021-2031, $ mn 67
Figure 36. Growth Stage of North America Onychomycosis Treatment Industry over the Forecast Period 69

List of Tables:

Table 1. Snapshot of North America Onychomycosis Treatment Market in Balanced Perspective, 2021-2031 16
Table 2. World Economic Outlook, 2021-2031 19
Table 3. Clinical Trials of Onychomycosis Treatment 25
Table 4. World Health Spending by Region, $ bn, 2013-2020 28
Table 5. Main Product Trends and Market Opportunities in North America Onychomycosis Treatment Market 32
Table 6. North America Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 40
Table 7. North America Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 47
Table 8. North America Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 53
Table 9. North America Onychomycosis Treatment Market by Country, 2021-2031, $ mn 60
Table 10. U.S. Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 64
Table 11. U.S. Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 64
Table 12. U.S. Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 64
Table 13. Canada Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 66
Table 14. Canada Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 66
Table 15. Canada Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 66
Table 16. Mexico Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 68
Table 17. Mexico Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 68
Table 18. Mexico Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 68
Table 19. Bausch Health Companies Inc.: Company Snapshot 73
Table 20. Bausch Health Companies Inc.: Business Segmentation 74
Table 21. Bausch Health Companies Inc.: Product Portfolio 74

Why Bonafide Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology
92%
Data Collection Techniques
97%
Our Research Team & Data Sourcing
93%
Data Science & Analytical Tools
81%
Data Visualization & Presentation Skills
86%
Project/ Report Delivery & After Sales Services
88%
Logo

North America Onychomycosis Treatment Market 2021-2031

We are friendly and approachable, give us a call.